Most studies in these cancers have shown that a higher expression of PARP-1 is associated with poor outcomes [8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,36,37]. Here, PARP1 is linked to cancer.